Sign inJoin waitlistJoin the waitlist

Lingbin Meng

Physician · Ohio State University College of Medicine

Credentials: · · · · · · ·

History

Ohio State University College of Medicine
2023–Present

Medical Oncology
2020–2022
Internal Medicine
AdventHealth Florida
2017–2020
ANHUI MED COLL, HEFEI, ANHUI, CHINA
2004–2008

Research

The role of short-chain fatty acids in intestinal barrier function, inflammation, oxidative stress, and colonic carcinogenesis
Review · Pharmacological Research · 2021 · 579 citations
Role of the gut microbiota in type 2 diabetes and related diseases
Review · Metabolism · 2021 · 312 citations
Targeting hypoxia in the tumor microenvironment: a potential strategy to improve cancer immunotherapy
Review · Journal of Experimental & Clinical Cancer Research · 2021 · 237 citations

YY
Yuanquan Yang
8 papers
AM
Amir Mortazavi
7 papers
BL
Baoqiong Liu
6 papers · 6 as a resident
FH
Feng Hong
6 papers
Zihai Li
6 papers
Adam Khorasanchi
5 papers · 4 as a fellow
Katharine Collier
5 papers
Mingjia Li
4 papers
PW
Peng Wang
4 papers
SW
Shang-Jui Wang
4 papers
Akshay Sood
3 papers
Anil Parwani
3 papers

Clinical trials

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Site PI · Recruiting · Phase 3
Alliance for Clinical Trials in Oncology
2025–2039
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
Site PI · Recruiting · Phase 1, Phase 2
Pathos AI, Inc.
2025–2029
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
Site PI · Recruiting · Phase 2, Phase 3
National Cancer Institute (NCI)
2024–2030